✦ LIBER ✦

1108 – Esense 2 - randomised controlled 6-month study of as-needed nalmefene: subgroup analysis of alcohol dependent patients with high drinking risk level

✍ Scribed by van den Brink, W.; Aubin, H.-J.; Sørensen, P.; Torup, L.; Mann, K.; Gual, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1107 – Esense 1 - randomised controlled

✍ van den Brink, W.; Aubin, H.-J.; Bladström, A.; Torup, L.; Mann, K.; Gual, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 33 KB

P.6.b.004 Efficacy of nalmefene as-neede

✍ Van den Brink, W.; Aubin, H.J.; Bladström, A.; Torup, L.; Gual, A.; Mann, K. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 78 KB

P.6.b.005 Long-term efficacy of nalmefen

✍ Mann, K.; Sørensen, P.; Torup, L.; Van den Brink, W.; Gual, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 63 KB

P.6.b.001 As-needed use of nalmefene in

✍ Sinclair, J.M.A.; Chick, J.; Sørensen, P.; Gual, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 55 KB

1105 – Long-term efficacy of nalmefene a

✍ van den Brink, W.; Sørensen, P.; Torup, L.; Mann, K.; Gual, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 33 KB

P.6.b.007 Clinical relevance of nalmefen

✍ Nutt, D.; Sorensen, P.; Torup, L.; Francois, C.; Aubin, H.J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 76 KB